MDRX - Veradigm (MDRX) Faces Lawsuit for Inflating Revenues- Hagens Berman | Benzinga

SAN FRANCISCO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Veradigm Inc. (NASDAQ:MDRX) investors who suffered substantial losses to submit your losses now.

Class Period: Feb. 26, 2021 – June 13, 2023
Lead Plaintiff Deadline: Jan. 22, 2024
Visit: www.hbsslaw.com/investor-fraud/MDRX  
Contact An Attorney Now: MDRX@hbsslaw.com
                                                    844-916-0895

Veradigm Inc. (MDRX) Securities Fraud Class Action:

"The litigation focuses on whether Veradigm may have intentionally inflated its revenues," said Reed Kathrein, the Hagens Berman partner leading the investigation.

On Nov. 17, 2023, Veradigm disclosed it had received a warning of potential de-listing from Nasdaq for failing to submit essential financial documents, including its Annual Report for FY2022 and Quarterly Reports for all quarters of FY2023.

The news follows the filing of a securities class action suit brought against Veradigm and its executives. There, investors allege Defendants misrepresented and concealed that Veradigm: (1) had overstated its historical revenues by at least $20 million; (2) artificially inflated revenues by recording duplicate transactions over more than 2 years; (3) artificially inflated earnings and margins and materially misrepresented demand for its ...

MDRX) Faces Lawsuit for Inflating Revenues- Hagens Berman>Full story available on Benzinga.com